ScienceDaily

FDA-approved epilepsy drug may help reverse osteoarthritis damage

Researchers at Yale have identified a promising new approach to osteoarthritis that could do more than simply ease pain. The epilepsy drug lacosamide appears to block a protein involved in both pain signaling and cartilage destruction, helping damaged joints shift back toward repair in preclinical studies.

By ScienceDaily

1 min read
FDA-approved epilepsy drug may help reverse osteoarthritis damage
AI-generated illustration

Got news to share with the events industry?

Submit a press release or story tip and reach thousands of event professionals.

Get in touch→

More in Medical Science

Related Insights